CUMBERLAND PHARMACEUTICALS INC — Director's Dealing 2015

Dec 4, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK: 0001087294
Period of Report: 2015-12-02

Reporting Person: Cearnal Martin E (Director, Sr VP/Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-02	Common Stock	A	1950	$5.58	Acquired	131856	Direct

Footnotes

F1: Restricted stock award will vest 100% on November 19, 2019.